Portal de Periódicos da CAPES

The current model of basal ganglia organization under scrutiny

1998; Wiley; Volume: 13; Issue: 2 Linguagem: Inglês

10.1002/mds.870130202

1531-8257

André Parent, Francesca Cicchetti,

Parkinson's Disease Mechanisms and Treatments

Movement DisordersVolume 13, Issue 2 p. 199-202 Editorial The current model of basal ganglia organization under scrutiny André Parent PhD, FRSC, Directeur, Corresponding Author André Parent PhD, FRSC, Directeur Laboratoire de Neurobiologie, Centre de recherche Université Laval Robert-Giffard, Beauport, Québec, CanadaLaboratoire de Neurobiologie, Centre de recherche Université Laval Robert-Giffard, 2601, Chemin de la Canardiére, Local F-6500, Beauport, Québec, Canada, G1J 2G3Search for more papers by this authorFrancesca Cicchetti MSc, Francesca Cicchetti MSc Laboratoire de Neurobiologie, Centre de recherche Université Laval Robert-Giffard, Beauport, Québec, CanadaSearch for more papers by this author André Parent PhD, FRSC, Directeur, Corresponding Author André Parent PhD, FRSC, Directeur Laboratoire de Neurobiologie, Centre de recherche Université Laval Robert-Giffard, Beauport, Québec, CanadaLaboratoire de Neurobiologie, Centre de recherche Université Laval Robert-Giffard, 2601, Chemin de la Canardiére, Local F-6500, Beauport, Québec, Canada, G1J 2G3Search for more papers by this authorFrancesca Cicchetti MSc, Francesca Cicchetti MSc Laboratoire de Neurobiologie, Centre de recherche Université Laval Robert-Giffard, Beauport, Québec, CanadaSearch for more papers by this author First published: 04 November 2004 https://doi.org/10.1002/mds.870130202Citations: 119AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Penney JB, Young AB. Speculation on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci 1983; 6: 73–94. 2 Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circutis linking basal ganglia and cortex. Annu Rev Neurobiol 1986; 9: 357–381. 3 Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366–375. 4 DeLong MR. Primate model of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13: 281–285. 5 Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992; 76: 53–61. 6 Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effects of GPipallidotomy on motor function in Parkinson's disease. Lancet 1995; 346: 1383–1387. 7 Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by GPi pallidotomy: 1 year pilot-study results. Ann Neurol 1996; 40: 355–366. 8 Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends Neurosci 1995; 18: 63–64. 9 Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996; 6: 751–758. 10 Kawaguchi Y, Wilson CL, Emson PC. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 1990; 10: 3421–3438. 11 Parent A, Charara A, Pinault D. Single striatofugal axons arborizing in both pallidal segments and in the substantia nigra in primates. Brain Res 1995; 698: 280–284. 12 Parent A, Cˆté PY, Lavoie B. Chemical anatomy of primate basal ganglia. Prog Neurobiol 1996; 46: 131–197. 13 Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995; 20: 91–127. 14 Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circutry. Brain Res Brain Res Rev 1995; 20: 128–154. 15 Vila M, Levy R, Herrero MT, et al. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I. J Neurosci 1997; 17: 765–773. 16 Levy R, Hazrati LN, Herrero MT, et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience 1997; 76: 335–343. 17 Hassani OK, Mouroux M, Féger J. Increased subthalamic neuronal activity after nigral dopamine lesion independent of disinhibition via the globus pallidus. Neuroscience 1996; 72: 105–115. 18 Chesselet MF, Delfs JM. Basal ganglia and movement disorders: an update. Trends Neurosci 1996; 19: 417–422. 19 Blanchet PJ, Boucher R, Bédard PJ. Excitotoxic lateral pallidotomy dose not relieve l-dopa-induced dyskinesia in MPTP parkinsonian monkeys. Brain Res 1996; 650: 32–39. 20 Cheruel F, Dormont JF, Farin D. Activity of the subthalamic nucleus in relation to motor performance in the cat. Exp Brain Res 1996; 108: 206–220. 21 Féger J. Updating the functional model of the basal ganglia [Letter]. Trends Neurosci 1997; 20: 152–153. 22 Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994; 117: 877–897. 23 Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249: 1436–1438. 24 Benazzouz A, Gross C, Féger J, et al. Reversal of rigidity and improvement of motor performance by subthalamic high frequency stimulation in MPTP treated monkeys. Eur J Neurosci 1993; 5: 382–389. 25 Limousin P, Pollack P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic stimulation. Lancet 1995; 345: 91–95. 26 Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994; 35: 1126–1130. 27 Gerlach M, Gsell W, Kornuber J, et al. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson's disease. Brain Res 1996; 741: 142–152. 28 Hardman CD, Halliday GM, McRitchie DA, Morris GL. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 1997; 56: 132–142. Citing Literature Volume13, Issue2March 1998Pages 199-202 ReferencesRelatedInformation